Methods of treating rheumatoid arthritis using IL-17 antagonists

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Mpofu, Shephard,Richards, Hanno,Thangavelu, Karthinathan,Machacek, Matthias

申请号：

AU2011325134

公开号：

AU2011325134B2

申请日:

2011.11.04

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

The disclosure relates to novel regimens for treating an inflammatory arthritis, e.g., rheumatoid arthritis (RA) patients, e.g., high risk RA patients, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., 1L-1 7 binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof, e.g., secukinumab) or IL-17 receptor binding molecule (e.g., IL- 17 antibody or antigen binding fragment thereof).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/